The Society for Clinical Research Sites (SCRS) brought on VirTrial as part of the society’s Global Impact Partner (GIP) program. Through this collaboration the telehealth and site solution provider will engage with SCRS and provide members expanded capabilities for clinical and virtual trials.
VirTrial solutions were developed after its leadership team worked at research sites on a cumulative 10,000 trials and enable remote solutions to reduce burden on patients and trial sites.
The company’s telemedicine approach offers a patient management program that combines video, text, and email for clinical trial sites. This program can be used to address specific patient and study needs securely and is compatible with any mobile device at any site.
“VirTrial’s virtual care platform provides much-needed ease for sites and patients alike as they navigate the challenges inherent to study visits,” Sean Soth, vice president of global business partnerships at SCRS said in a statement.
According to the solutions company, it allows sites to conduct remote visits with patients while using their own mobile devices. As a GIP with SCRS, society members will have access to the site solution services enabling stakeholders to perform virtual and remote clinical trials at a higher rate.
The site solutions company stated that its vision is to replace 25-40% of standard trials with remote or clinical trial hybrid site visits. Additionally, the company states it’s platform is best-suited for Phase III/IV studies, rare disease trials, and as a way to replace traditional phone calls within protocol.
Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity.
